← Back to feedRead original →
VERIFIEDET Markets·positive
Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividend
AI Summary
- ·Sun Pharma's Q4 profit after tax rose 26% year-on-year to Rs 2,714 crore.
- ·The company's board has approved a dividend of Rs 5 per share.
- ·Profit after tax fell 19% sequentially from Rs 3,369 crore in Q3FY26.